Francis 'Chip' D Moore

Francis 'Chip' D Moore, MD

Professor

Department: MD-SURGERY-SURGONC-BMSE
Business Phone: (352) 265-0535
Business Email: francis.moore@ufl.edu

About Francis 'Chip' D Moore

Francis Moore, Jr., MD, is a Professor in the University of Florida College of Medicine’s Department of Surgery.

Dr. Moore attended Harvard University for both his undergraduate and medical degrees. Following medical school, he interned and completed his residency at Peter Bent Brigham Hospital in the Department of Surgery. He also completed a trauma and burn research fellowship in Harvard Medical School’s Division of Rheumatology, Allergy and Immunology. He later served as chief resident surgeon for both West Roxbury VA Hospital and Brigham and Women’s Hospital.

After his post-graduate training, Dr. Moore was appointed to the faculty at Harvard Medical School and to the surgical staff at Brigham and Women’s. He was P.I. of a P50 Trauma Center Grant for 17 years. In 2000, he became the Division Chief of General and GI Surgery, and in 2004, Professor of Surgery. In 2010, he was honored with the Moore Chair in Surgery. He concluded his career as the Vice Chairman of the Department of Surgery at Brigham and Women’s Hospital. Dr. Moore has served as President of Massachusetts Chapter of the American College of Surgeons, the Boston Surgical Society, and the New England Surgical Society.

Dr. Moore has received multiple awards throughout his career including the Joseph Murray-Simon Simonian Award for Excellence in Research Mentoring and being recognized as one of America’s Top Doctors for Cancer. He is also a member of various professional organizations, including the American Thyroid Association, the American Association of Endocrine Surgeons, and the American Surgical Association.

Accomplishments

Moore Chair
2010 · Brigham and Women's Hospital
President
2008-2009 · New England Surgical Society
President
2008-2009 · Boston Surgical Society
President
2003-2005 · Massachusetts Chapter of the American College of Surgeons

Board Certifications

  • Thyroid Surgery
    American Surgical Association

Clinical Profile

Subspecialties
  • Colon and Rectal Surgery
  • Surgical Oncology
Areas of Interest
  • Graves disease
  • Primary hyperparathyroidism
  • Thyroid cancer
  • Thyroid gland removal
  • Toxic nodular goiter

Research Profile

Areas of Interest
  • parathyroid surgery
  • thyroid cancer

Publications

Academic Articles
2024
Impact of age on genomic alterations and the tumor immune microenvironment in papillary thyroid cancer.
Endocrine-related cancer. 31(12) [DOI] 10.1530/ERC-23-0341. [PMID] 39315956.
2018
Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study.
Clinical cancer research : an official journal of the American Association for Cancer Research. 24(7):1546-1553 [DOI] 10.1158/1078-0432.CCR-17-2297. [PMID] 29301825.
2017
Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer.
Journal of the American College of Surgeons. 224(6):1021-1027 [DOI] 10.1016/j.jamcollsurg.2016.12.007. [PMID] 28017809.
2016
Identification of Novel Oncogenic Mutations in Thyroid Cancer.
Journal of the American College of Surgeons. 222(6):1036-1043.e2 [DOI] 10.1016/j.jamcollsurg.2015.12.047. [PMID] 27010584.
2013
Thyroid nodule size and prediction of cancer.
The Journal of clinical endocrinology and metabolism. 98(2):564-70 [DOI] 10.1210/jc.2012-2968. [PMID] 23275525.
2011
Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer.
The Journal of clinical endocrinology and metabolism. 96(3):E554-65 [DOI] 10.1210/jc.2010-1800. [PMID] 21190978.
2011
Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.
Surgery. 150(6):1168-77 [DOI] 10.1016/j.surg.2011.09.043. [PMID] 22136837.
2010
Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met inhibition in papillary thyroid cancer.
Molecular cancer research : MCR. 8(9):1217-26 [DOI] 10.1158/1541-7786.MCR-10-0162. [PMID] 20736296.
2010
Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid cancer cells with the BRAFV600E mutation.
Thyroid : official journal of the American Thyroid Association. 20(6):615-22 [DOI] 10.1089/thy.2009.0415. [PMID] 20470206.
2009
Galectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid cancer cells.
Biochemical and biophysical research communications. 379(2):626-31 [DOI] 10.1016/j.bbrc.2008.12.153. [PMID] 19124005.
2009
Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer.
Molecular cancer research : MCR. 7(10):1655-62 [DOI] 10.1158/1541-7786.MCR-09-0274. [PMID] 19825987.

Education

Surgery Chief Resident
1983-1984 · Brigham and Women's Hospital
Surgery Senior Resident
1981-1983 · Brigham and Women's Hospital
Surgery Junior Resident
1977-1979 · Peter Bent Brigham Hospital – Boston MA
Surgery Intern
1976-1977 · Peter Bent Brigham Hospital – Boston MA
Medical School
1976 · Harvard Medical School
A.B. – Cum Laude
1972 · Harvard College

Contact Details

Phones:
Business:
(352) 265-0535
Emails:
Addresses:
Business Mailing:
PO Box 100109
GAINESVILLE FL 32610
Business Street:
1600 SW ARCHER RD
GAINESVILLE FL 32610